These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 17090282

  • 1. Safety, tolerability, and efficacy of tegaserod over 13 months in patients with chronic constipation.
    Müller-Lissner S, Kamm MA, Musoglu A, Earnest DL, Dunger-Baldauf C, Shetzline MA.
    Am J Gastroenterol; 2006 Nov; 101(11):2558-69; quiz 2671. PubMed ID: 17090282
    [Abstract] [Full Text] [Related]

  • 2. Safety and tolerability of tegaserod in patients with chronic constipation: pooled data from two phase III studies.
    Quigley EM, Wald A, Fidelholtz J, Boivin M, Pecher E, Earnest D.
    Clin Gastroenterol Hepatol; 2006 May; 4(5):605-13. PubMed ID: 16678076
    [Abstract] [Full Text] [Related]

  • 3. Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study.
    Kamm MA, Müller-Lissner S, Talley NJ, Tack J, Boeckxstaens G, Minushkin ON, Kalinin A, Dzieniszewski J, Haeck P, Fordham F, Hugot-Cournez S, Nault B.
    Am J Gastroenterol; 2005 Feb; 100(2):362-72. PubMed ID: 15667494
    [Abstract] [Full Text] [Related]

  • 4. Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms.
    Fidelholtz J, Smith W, Rawls J, Shi Y, Zack A, Rüegg P, Lefkowitz M.
    Am J Gastroenterol; 2002 May; 97(5):1176-81. PubMed ID: 12014724
    [Abstract] [Full Text] [Related]

  • 5. Review article: the safety profile of tegaserod.
    Schoenfeld P.
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():25-30. PubMed ID: 15521852
    [Abstract] [Full Text] [Related]

  • 6. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
    Chey WD, Paré P, Viegas A, Ligozio G, Shetzline MA.
    Am J Gastroenterol; 2008 May; 103(5):1217-25. PubMed ID: 18477346
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of tegaserod in chronic constipation in men.
    Fried M, Johanson JF, Gwee KA, Wagner A, Pecher E, Rueegg P.
    Am J Gastroenterol; 2007 Feb; 102(2):362-70. PubMed ID: 17156137
    [Abstract] [Full Text] [Related]

  • 8. The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.
    Bardhan KD, Forbes A, Marsden CL, Mason T, Short G.
    Aliment Pharmacol Ther; 2004 Jul 15; 20(2):213-22. PubMed ID: 15233702
    [Abstract] [Full Text] [Related]

  • 9. Tegaserod: long-term treatment for irritable bowel syndrome patients with constipation in primary care.
    Layer P, Keller J, Mueller-Lissner S, Rüegg P, Loeffler H.
    Digestion; 2005 Jul 15; 71(4):238-44. PubMed ID: 16024929
    [Abstract] [Full Text] [Related]

  • 10. [A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of tegaserod in Chinese patients with constipation-predominant irritable bowel syndrome].
    Tegaserod Clinical Research Group.
    Zhonghua Nei Ke Za Zhi; 2003 Feb 15; 42(2):88-90. PubMed ID: 12783702
    [Abstract] [Full Text] [Related]

  • 11. Review article: tegaserod for chronic constipation.
    Johanson JF.
    Aliment Pharmacol Ther; 2004 Nov 15; 20 Suppl 7():20-4. PubMed ID: 15521851
    [Abstract] [Full Text] [Related]

  • 12. Tolerability and safety of alosetron during long-term administration in female and male irritable bowel syndrome patients.
    Wolfe SG, Chey WY, Washington MK, Harding J, Heath AT, McSorley DJ, Dukes GE, Hunt CM.
    Am J Gastroenterol; 2001 Mar 15; 96(3):803-11. PubMed ID: 11280555
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of linaclotide for patients with chronic constipation.
    Lembo AJ, Kurtz CB, Macdougall JE, Lavins BJ, Currie MG, Fitch DA, Jeglinski BI, Johnston JM.
    Gastroenterology; 2010 Mar 15; 138(3):886-95.e1. PubMed ID: 20045700
    [Abstract] [Full Text] [Related]

  • 14. Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation.
    Müller-Lissner S, Holtmann G, Rueegg P, Weidinger G, Löffler H.
    Aliment Pharmacol Ther; 2005 Jan 01; 21(1):11-20. PubMed ID: 15644040
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.
    Krause R, Ameen V, Gordon SH, West M, Heath AT, Perschy T, Carter EG.
    Am J Gastroenterol; 2007 Aug 01; 102(8):1709-19. PubMed ID: 17509028
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of tegaserod for functional constipation in Chinese subjects: a randomized double-blind controlled trial in a single centre.
    On Chan AO, Mo Hui W, Leung G, Hu WH, Lam SK, Wong BC.
    Aliment Pharmacol Ther; 2007 Feb 15; 25(4):463-9. PubMed ID: 17270002
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG, Orońska A, Kaczmarek Z, Kaasa S, Colberg T, Nolte T.
    Clin Ther; 2009 Jun 15; 31(6):1177-91. PubMed ID: 19695386
    [Abstract] [Full Text] [Related]

  • 18. Tegaserod for treating chronic constipation in elderly patients.
    Baun RF, Levy HB.
    Ann Pharmacother; 2007 Feb 15; 41(2):309-13. PubMed ID: 17227825
    [Abstract] [Full Text] [Related]

  • 19. Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome.
    Chey WD, Chey WY, Heath AT, Dukes GE, Carter EG, Northcutt A, Ameen VZ.
    Am J Gastroenterol; 2004 Nov 15; 99(11):2195-203. PubMed ID: 15555002
    [Abstract] [Full Text] [Related]

  • 20. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.
    Aliment Pharmacol Ther; 2005 Feb 15; 21(4):435-44. PubMed ID: 15709995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.